Biocept Inc (BIOC.OQ) Analyst Research| Reuters.com
Edition:
United States

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.60USD
24 Jun 2016
Change (% chg)

$-0.05 (-7.12%)
Prev Close
$0.65
Open
$0.60
Day's High
$0.63
Day's Low
$0.58
Volume
87,070
Avg. Vol
42,598
52-wk High
$3.09
52-wk Low
$0.57

Reports per page
Name Age Since Current Position

David Hale

67 2014 Non-Executive Chairman of the Board

Michael Nall

52 2013 President, Chief Executive Officer, Director

Mark Foletta

54 2015 Interim Chief Financial Officer

Lyle Arnold

68 2011 Senior Vice President - Research & Development, Chief Scientific Officer

Veena Singh

40 2014 Senior Vice President, Senior Medical Director